{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:27:37Z","timestamp":1786987657584,"version":"build-2736575974"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.det.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T07:55:56Z","timestamp":1681458956000},"page":"393-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Disorders of Facial Hyperpigmentation"],"prefix":"10.1016","volume":"41","author":[{"given":"Nicole C.","family":"Syder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Quarshie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Elbuluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2023.02.005_bib1","author":"Vashi"},{"issue":"12","key":"10.1016\/j.det.2023.02.005_bib2","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.31557\/APJCP.2019.20.12.3723","article-title":"The Role of Stem Cell Factor in Hyperpigmented Skin Lesions","volume":"20","author":"Atef","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40257-016-0239-8","article-title":"Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment","volume":"18","author":"Vashi","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib4","author":"Grimes"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","article-title":"Melasma: an Up-to-Date Comprehensive Review","volume":"7","author":"Ogbechie-Godec","year":"2017","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-4632.2012.05748.x","article-title":"Epidemiology of melasma in Brazilian patients: a multicenter study","volume":"53","author":"Hexsel","year":"2014","journal-title":"Int J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2023.02.005_bib7","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1468-3083.2012.04655.x","article-title":"Extra-facial melasma: clinical, histopathological, and immunohistochemical case-control study","volume":"27","author":"Ritter","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.det.2023.02.005_bib8","doi-asserted-by":"crossref","DOI":"10.5070\/D32510045810","article-title":"Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies","volume":"25","author":"Rajanala","year":"2019","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib9","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s10103-018-2658-7","article-title":"Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment","volume":"34","author":"Gao","year":"2019","journal-title":"Lasers Med Sci"},{"issue":"5","key":"10.1016\/j.det.2023.02.005_bib10","first-page":"141","article-title":"Clues to the Pathogenesis of Melasma from its Histologic Findings","volume":"1","author":"Kwon","year":"2014","journal-title":"Journal of Pigmentary Disorders"},{"key":"10.1016\/j.det.2023.02.005_bib11","author":"Melasma"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/phpp.12086","article-title":"Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial","volume":"30","author":"Castanedo-Cazares","year":"2014","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"7","key":"10.1016\/j.det.2023.02.005_bib13","first-page":"712","article-title":"Impact of Iron-Oxide Containing Formulations Against Visible Light-Induced Skin Pigmentation in Skin of Color Individuals","volume":"19","author":"Dumbuya","year":"2020","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40257-019-00488-w","article-title":"Melasma Treatment: An Evidence-Based Review","volume":"21","author":"McKesey","year":"2020","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijwd.2017.01.004","article-title":"A\u00a0review of laser and light therapy in melasma","volume":"3","author":"Trivedi","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"7","key":"10.1016\/j.det.2023.02.005_bib16","first-page":"20","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis","year":"2010","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib17","author":"Saedi"},{"key":"10.1016\/j.det.2023.02.005_bib18","first-page":"1","article-title":"A\u00a0Focused review on the pathophysiology of post-inflammatory hyperpigmentation","author":"Maghfour","year":"2022","journal-title":"Pigment Cell & Melanoma Research."},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2017.01.035","article-title":"Postinflammatory hyperpigmentation: A comprehensive overview: Epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique","volume":"77","author":"Silpa-archa","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib20","series-title":"Paller and Mancini \u2013 hurwitz clinical pediatric Dermatology","first-page":"287","article-title":"Disorders of pigmentation","volume":"11","author":"Paller","year":"2022"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40257-017-0333-6","article-title":"Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment","volume":"19","author":"Kaufman","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib22","first-page":"344","article-title":"The Use of Tranexamic Acid to Prevent and Treat Post-Inflammatory Hyperpigmentation","volume":"20","author":"Lindgren","year":"2021","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib23","series-title":"Dermatology: 2-Volume Set","first-page":"2364","article-title":"Lasers and Other Energy-Based Therapies","volume":"137","author":"Zachary","year":"2018"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lsm.22454","article-title":"Treatment of pigmentary disorders in patients with skin of color with a novel 755 nm picosecond, Q-switched ruby, and Q-switched Nd:YAG nanosecond lasers: A retrospective photographic review","volume":"48","author":"Levin","year":"2016","journal-title":"Lasers Surg Med"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib25","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2021.07.080","article-title":"An update on cosmetic procedures in people of color. Part 2: Neuromodulators, soft tissue augmentation, chemexfoliating agents, and laser hair reduction","volume":"86","author":"Qui\u00f1onez","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib26","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4103\/2229-5178.193898","article-title":"A\u00a0descriptive study of facial acanthosis nigricans and its association with body mass index, waist circumference and insulin resistance using HOMA2 IR","volume":"7","author":"Verma","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.det.2023.02.005_bib27","author":"Larocca"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/Pigmentinternational.Pigmentinternational_32_17","article-title":"Maturational hyperpigmentation: Clinico-dermoscopic and histopathological profile of a new cutaneous marker of metabolic syndrome","volume":"5","author":"Sonthalia","year":"2018","journal-title":"Pigment Int"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib29","doi-asserted-by":"crossref","first-page":"e2020046","DOI":"10.5826\/dpc.1002a46","article-title":"Maturational Hyperpigmentation: Cutaneous Marker of Metabolic Syndrome","volume":"10","author":"Sonthalia","year":"2020","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.det.2023.02.005_bib31","series-title":"VisualDX","article-title":"Maturational hyperpigmentation","author":"Wong","year":"2022"},{"key":"10.1016\/j.det.2023.02.005_bib32","author":"Maderal"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/idoj.IDOJ_855_20","article-title":"Clinico-investigative Study of Facial Acanthosis Nigricans","volume":"13","author":"Shah","year":"2022","journal-title":"Indian Dermatol Online J"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4103\/2229-5178.137765","article-title":"An approach to acanthosis nigricans","volume":"5","author":"Phiske","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijwd.2018.08.003","article-title":"Erythema dyschromicum perstans: A case report and systematic review of histologic presentation and treatment","volume":"4","author":"Leung","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1468-3083.2005.01203.x","article-title":"Erythema dyschromicum perstans in children: a report of 14 cases","volume":"19","author":"Torrelo","year":"2005","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.det.2023.02.005_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5070\/D39218V6BN","article-title":"Erythema dyschromicum perstans","volume":"16","author":"Tlougan","year":"2010","journal-title":"Dermatol Online J"},{"issue":"11","key":"10.1016\/j.det.2023.02.005_bib38","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/1346-8138.13002","article-title":"Clinical and histological aspect of erythema dyschromicum perstans in Korea: A review of 68 cases","volume":"42","author":"Chang","year":"2015","journal-title":"J\u00a0Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.02.005_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ijd.13806","article-title":"Lichen planus pigmentosus and its variants: review and update","volume":"57","author":"Robles-M\u00e9ndez","year":"2018","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.det.2023.02.005_bib40","doi-asserted-by":"crossref","first-page":"20713","DOI":"10.5070\/D31912020713","article-title":"Lichen planus pigmentosus","volume":"19","author":"Rieder","year":"2013","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2133.2012.11146.x","article-title":"Frontal fibrosing alopecia and lichen planus pigmentosus: is there a link?","volume":"168","author":"Dlova","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.02.005_bib42","first-page":"335","article-title":"Frontal fibrosing alopecia: cutaneous associations in women with skin of color","volume":"102","author":"Krueger","year":"2018","journal-title":"Cutis"},{"issue":"11","key":"10.1016\/j.det.2023.02.005_bib43","first-page":"44","article-title":"A\u00a0Case of Lichen Planus Pigmentosus with Facial Dyspigmentation Responsive to Combination Therapy with Chemical Peels and Topical Retinoids","volume":"9","author":"Wolff","year":"2016","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib44","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1111\/ajd.13060","article-title":"A\u00a0successful combination therapy of tacrolimus, hydroxychloroquine and picosecond laser for lichen planus pigmentosus","volume":"60","author":"Wu","year":"2019","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.12862","article-title":"Modified phenol peels for treatment-refractory hyperpigmentation of lichen planus pigmentosus: A retrospective clinico-dermoscopic analysis","author":"Sonthalia","year":"2019","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib46","author":"Schaffer"},{"key":"10.1016\/j.det.2023.02.005_bib47","article-title":"Nevi of Ota: the unusual birthmarks\u201d: a case review","volume":"2013","author":"Mohan","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jaad.2019.03.016","article-title":"Comparison of a picosecond alexandrite laser versus a Q-switched alexandrite laser for the treatment of nevus of Ota: A randomized, split-lesion, controlled trial","volume":"83","author":"Ge","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib49","doi-asserted-by":"crossref","first-page":"e14384","DOI":"10.1111\/dth.14384","article-title":"Combination of 1064-nm Q-switched neodymium-doped yttrium-aluminum-garnet laser with Modified Jessner\u2019s peel for the treatment of Nevus of Ota: A case series of seven patients","volume":"33","author":"Raj","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaad.2008.10.054","article-title":"Acquired bilateral nevus of Ota-like macules (Hori nevus): etiologic and therapeutic considerations","volume":"61","author":"Park","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2133.2005.06689.x","article-title":"Characteristics of Hori naevus: a prospective analysis","volume":"154","author":"Ee","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib52","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(84)80313-8","article-title":"Acquired, bilateral nevus of Ota-like macules","volume":"10","author":"Hori","year":"1984","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.02.005_bib53","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2133.2005.06381.x","article-title":"Acquired symmetrical dermal melanocytosis (naevus of Hori) developing after aggravated atopic dermatitis","volume":"152","author":"Murakami","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib54","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0974-2077.172198","article-title":"Novel treatment of Hori\u2019s nevus: A combination of fractional nonablative 2,940-nm Er:YAG and low-fluence 1,064-nm Q-switched Nd:YAG laser","volume":"8","author":"Tian","year":"2015","journal-title":"J\u00a0Cutan Aesthet Surg"},{"issue":"11","key":"10.1016\/j.det.2023.02.005_bib55","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/DSS.0000000000002332","article-title":"Treatment of Laser-Responsive Dermal Pigmentary Conditions in Type III-IV Asian Skin With a 755-nm Picosecond Pulse Duration Laser: A Retrospective Review of Its Efficacy and Safety","volume":"46","author":"Koh","year":"2020","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2023.02.005_bib56","series-title":"Habif\u2019s clinical Dermatology","first-page":"748","article-title":"Light-Related Diseases and Disorders of Pigmentation","author":"Dinulos","year":"2021"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/pcmr.12232","article-title":"Sun-induced freckling: ephelides and solar lentigines","volume":"27","author":"Praetorius","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"issue":"16","key":"10.1016\/j.det.2023.02.005_bib58","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/hmg\/10.16.1701","article-title":"The melanocortin-1-receptor gene is the major freckle gene","volume":"10","author":"Bastiaens","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/0974-2077.104914","article-title":"A\u00a0split-face comparative study of 70% trichloroacetic acid and 80% phenol spot peel in the treatment of freckles","volume":"5","author":"Mradula","year":"2012","journal-title":"J\u00a0Cutan Aesthet Surg"},{"issue":"5 Suppl 2","key":"10.1016\/j.det.2023.02.005_bib60","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1016\/j.jaad.2005.12.043","article-title":"Treatment of solar lentigines","volume":"54","author":"Ortonne","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib61","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/ajd.12715","article-title":"Chemical peels: A review of current practice","volume":"59","author":"O\u2019Connor","year":"2018","journal-title":"Australas J Dermatol"},{"issue":"12","key":"10.1016\/j.det.2023.02.005_bib62","first-page":"797","article-title":"Pigmentation Disorders: Diagnosis and Management","volume":"96","author":"Plensdorf","year":"2017","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-4632.2009.03887.x","article-title":"Defining lichenoid photodermatitis","volume":"48","author":"Collazo","year":"2009","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2023.02.005_bib64","first-page":"242","article-title":"Photolichenoid dermatitis: a presenting sign of human immunodeficiency virus","volume":"104","author":"Curtiss","year":"2019","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archderm.1972.01620100046011","article-title":"Photosensitive lichenoid eruption associated with demeclocycline","volume":"106","author":"Jones","year":"1972","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.02.005_bib66","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1994.01690050077013","article-title":"Lichenoid photoeruptions in human immunodeficiency virus infection","volume":"130","author":"Berger","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib67","article-title":"Lichenoid tissue reaction\/interface dermatitis: Recognition, classification, etiology, and clinicopathological overtones","year":"2011","journal-title":"Indian J Dermatol, Venereol Leprol"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/ijstd.IJSTD_51_20","article-title":"Clinical and histopathological aspects of lichenoid dermatitis in patients of retroviral diseases","volume":"43","author":"Tambe","year":"2022","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"10.1016\/j.det.2023.02.005_bib69","series-title":"StatPearls","article-title":"Phototherapy","author":"Rathod","year":"2022"},{"key":"10.1016\/j.det.2023.02.005_bib70","series-title":"StatPearls","article-title":"Drug Induced Pigmentation","author":"Hassan","year":"2022"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib71","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clindermatol.2013.05.026","article-title":"Pigmentation disorders: hyperpigmentation and hypopigmentation","volume":"32","author":"Nicolaidou","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib72","unstructured":"Desai N, Alexis AF, DeLeo VA. Facial Hyperpigmentation Caused by Diltiazem Hydrochloride. :3."},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib73","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jaad.2008.09.015","article-title":"Cutaneous drug eruptions: a 5-year experience","volume":"59","author":"Gerson","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib75","doi-asserted-by":"crossref","first-page":"302","DOI":"10.12788\/cutis.0538","article-title":"Going Beyond Hydroquinone: Alternative Skin Lightning Agents","volume":"109","author":"Syder","year":"2022","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00128071-200405030-00004","article-title":"Optimal Management of Recalcitrant Disorders of Hyperpigmentation in Dark-Skinned Patients","volume":"5","author":"Stratigos","year":"2004","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib77","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/00128071-200304060-00005","article-title":"Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions : implications for management","volume":"4","author":"Crowson","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"10.1016\/j.det.2023.02.005_bib78","first-page":"1609","article-title":"Effective treatment of psychotropic drug-induced facial hyperpigmentation with a 755-nm Q-switched alexandrite laser","volume":"34","author":"Wee","year":"2008","journal-title":"Dermatol Surg"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib79","doi-asserted-by":"crossref","first-page":"380.e1","DOI":"10.1016\/j.ajem.2016.08.056","article-title":"Periorbital melanosis","volume":"35","author":"Noble","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib80","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaci.2009.08.019","article-title":"How allergic are \u201callergic shiners\u201d","volume":"125","author":"Kelso","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib81","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/idoj.IDOJ_491_20","article-title":"Assessment of Patients with Periorbital Melanosis for Hyperinsulinemia and Insulin Resistance","volume":"12","author":"Thappa","year":"2021","journal-title":"Indian Dermatol Online J"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib82","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.fsc.2022.03.005","article-title":"Treatment of Periorbital Vascularity, Erythema, and Hyperpigmentation","volume":"30","author":"Samaan","year":"2022","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib83","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/DSS.0000000000002484","article-title":"Treatments of Periorbital Hyperpigmentation: A Systematic Review","volume":"47","author":"Michelle","year":"2021","journal-title":"Dermatol Surg"},{"issue":"5","key":"10.1016\/j.det.2023.02.005_bib84","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/14764172.2016.1157363","article-title":"Combination of microneedling and 10% trichloroacetic acid peels in the management of infraorbital dark circles","volume":"18","author":"Kontochristopoulos","year":"2016","journal-title":"J\u00a0Cosmet Laser Ther"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib85","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jocd.12536","article-title":"Treatment of periorbital dark circles: Comparative study of carboxy therapy vs chemical peeling vs mesotherapy","volume":"18","author":"Ahmed","year":"2019","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib86","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4103\/0019-5154.169122","article-title":"Exogenous Ochronosis","volume":"60","author":"Bhattar","year":"2015","journal-title":"Indian J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2133.1989.tb07787.x","article-title":"Exogenous ochronosis: an epidemiological study","volume":"120","author":"Hardwick","year":"1989","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40257-015-0126-8","article-title":"Exogenous ochronosis: a comprehensive review of the diagnosis, epidemiology, causes, and treatments","volume":"16","author":"Simmons","year":"2015","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"10.1016\/j.det.2023.02.005_bib89","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1524-4725.1990.tb00326.x","article-title":"Hydroquinone-induced localized exogenous ochronosis treated with dermabrasion and CO2 laser","volume":"16","author":"Diven","year":"1990","journal-title":"J\u00a0Dermatol Surg Oncol"},{"issue":"1","key":"10.1016\/j.det.2023.02.005_bib90","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/14764172.2012.748198","article-title":"Effect of combination of 1064 nm Q-switched Nd:YAG and fractional carbon dioxide lasers for treating exogenous ochronosis","volume":"15","author":"Kanechorn-Na-Ayuthaya","year":"2013","journal-title":"J\u00a0Cosmet Laser Ther"},{"issue":"5","key":"10.1016\/j.det.2023.02.005_bib91","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/14764172.2012.758379","article-title":"Exogenous ochronosis - successful outcome after treatment with Q-switched Nd:YAG laser","volume":"15","author":"Tan","year":"2013","journal-title":"J\u00a0Cosmet Laser Ther"},{"key":"10.1016\/j.det.2023.02.005_bib92","article-title":"A\u00a0case of ochronosis successfully treated with the picosecond laser","author":"M\u00e9ndez Baca","year":"2018","journal-title":"J\u00a0Cosmet Dermatol"},{"key":"10.1016\/j.det.2023.02.005_bib93","series-title":"StatPearls. StatPearls publishing","article-title":"Riehl Melanosis","author":"Daadaa","year":"2022"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/DAD.0000000000001515","article-title":"Histopathological Features of Riehl Melanosis","volume":"42","author":"Kim","year":"2020","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib95","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/jocd.13153","article-title":"Combination therapy with salicylic acid chemical peels, glycyrrhizin compound, and vitamin C for Riehl\u2019s melanosis","volume":"19","author":"Wang","year":"2020","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/09546634.2016.1187706","article-title":"A\u00a0pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl\u2019s Melanosis","volume":"28","author":"Kwon","year":"2017","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"8","key":"10.1016\/j.det.2023.02.005_bib97","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s13312-018-1368-3","article-title":"Actinic Lichen Planus","volume":"55","author":"Tiwary","year":"2018","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.det.2023.02.005_bib98","article-title":"Dyschromic actinic lichen planus","author":"Ashraf","year":"2021","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2023.02.005_bib99","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jdcr.2018.02.008","article-title":"Pigmented actinic lichen planus (PALP) mimicking lentigo maligna melanoma: Usefulness of in\u00a0vivo reflectance confocal microscopy in diagnosis and follow-up","volume":"4","author":"Venturini","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"2","key":"10.1016\/j.det.2023.02.005_bib100","first-page":"31","article-title":"Actinic lichen planus of unusual presentation","volume":"19","author":"Mebazaa","year":"2010","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib101","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1468-3083.2007.02325.x","article-title":"Relapsing lichen actinicus successfully treated with cyclosporin","volume":"22","author":"Gallo","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2023.02.005_bib102","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2133.2010.09857.x","article-title":"Pigmented actinic lichen planus successfully treated with intense pulsed light","volume":"163","author":"Santos-Juanes","year":"2010","journal-title":"Br J Dermatol"},{"issue":"1143","key":"10.1016\/j.det.2023.02.005_bib103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/postgradmedj-2020-137504","article-title":"Post-chikungunya hyperpigmentation","volume":"97","author":"Sil","year":"2021","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.det.2023.02.005_bib104","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/pde.13883","article-title":"The chik sign in dengue","volume":"36","author":"Bhatia","year":"2019","journal-title":"Pediatr Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523000153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523000153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:46:39Z","timestamp":1760006799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863523000153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0733863523000153"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2023.02.005","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disorders of Facial Hyperpigmentation","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}